Predictive Oncology and Cancer Research Horizons have partnered to pursue development of cancer drugs Read more
Syneos Health Collaborates with Microsoft to Accelerate AI Across the Clinical to Commercial Continuum Read more
BioNTech and OncoC4 Announce Strategic Collaboration to Co-Develop and Commercialize Novel Checkpoint Antibody in Multiple Solid Tumor Indications Read more
Hovione and Ripple Enter Strategic Partnership to Expand Epidel Platform into Non-Ophthalmic Space Read more
Ipsen receives new FDA PDUFA date for investigational palovarotene for the treatment of people with FOP Read more
InvisiShield Technologies Collaborates with Gladstone Institutes to Accelerate Development of Intranasal Preventatives against SARS-CoV-2, Influenza, and RSV Read more
Processa Pharmaceuticals Announces First Patient Dosed in the 300 mg Dose Group with Next Generation Chemotherapy-Capecitabine Read more
Alphamab Oncology Announces the First Patient Dosed in the Phase I Trial of Anti-HER2 bispecific ADC JSKN003 Read more